Recent evidence also suggests that the use of oral antihyperglycemic medications, like metformin, DPP‐4 inhibitors, and SGLT‐2 inhibitors, may improve overall and cancer‐specific survival, while sulfonylureas have often been associated with poorer survival.36, 37, 38, 39, 40, 41, 42, 43, 44, 45. This evidence concerns the gene SLC5A2 and cancer.